MA53273A - Vésicules extracellulaires pour inhalation - Google Patents

Vésicules extracellulaires pour inhalation

Info

Publication number
MA53273A
MA53273A MA053273A MA53273A MA53273A MA 53273 A MA53273 A MA 53273A MA 053273 A MA053273 A MA 053273A MA 53273 A MA53273 A MA 53273A MA 53273 A MA53273 A MA 53273A
Authority
MA
Morocco
Prior art keywords
inhalation
extracellular vesicles
vesicles
extracellular
Prior art date
Application number
MA053273A
Other languages
English (en)
Inventor
Gerard Bernard Mccauley
Original Assignee
Omnispirant Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omnispirant Ltd filed Critical Omnispirant Ltd
Publication of MA53273A publication Critical patent/MA53273A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0091—Purification or manufacturing processes for gene therapy compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/005—Sprayers or atomisers specially adapted for therapeutic purposes using ultrasonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Manufacturing & Machinery (AREA)
  • Otolaryngology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA053273A 2018-08-10 2019-08-09 Vésicules extracellulaires pour inhalation MA53273A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18188591 2018-08-10
EP19154302 2019-01-29

Publications (1)

Publication Number Publication Date
MA53273A true MA53273A (fr) 2021-06-16

Family

ID=67766129

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053273A MA53273A (fr) 2018-08-10 2019-08-09 Vésicules extracellulaires pour inhalation

Country Status (15)

Country Link
US (2) US12029821B2 (fr)
EP (1) EP3833331A1 (fr)
JP (1) JP7480143B2 (fr)
KR (1) KR102875565B1 (fr)
CN (1) CN112566626A (fr)
AU (1) AU2019316742B2 (fr)
BR (1) BR112021002286A2 (fr)
CA (1) CA3108605A1 (fr)
CL (1) CL2021000334A1 (fr)
IL (1) IL280658B2 (fr)
MA (1) MA53273A (fr)
MX (1) MX2021001574A (fr)
SG (1) SG11202100870UA (fr)
WO (1) WO2020030817A1 (fr)
ZA (1) ZA202100886B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020030817A1 (fr) * 2018-08-10 2020-02-13 Omnispirant Limited Vésicules extracellulaires pour inhalation
CN113384597A (zh) * 2020-03-13 2021-09-14 西比曼生物科技(上海)有限公司 含人体细胞衍生的细胞膜外囊泡的雾化吸入制剂、制法及其应用
CN111500607B (zh) * 2020-03-13 2022-05-03 首都医科大学附属北京口腔医院 种植体周围抗炎用融合基因、外泌体、生物涂料以及制备方法和应用
EP4122475A4 (fr) * 2020-03-16 2024-07-03 Exostemtech Co., Ltd. Nouvelle utilisation d'un dispositif de filtration à flux tangentiel pour préparer un exosome fonctionnel
WO2021207126A1 (fr) * 2020-04-06 2021-10-14 The Trustees Of Dartmouth College Compositions et méthodes de traitement d'infections bactériennes
CN113244173A (zh) * 2021-04-06 2021-08-13 浙江大学医学院附属邵逸夫医院 一种间充质干细胞外泌体改性修饰囊泡及其制备方法
CN115212230B (zh) * 2021-04-21 2024-12-27 时比曼生物科技(上海)有限公司 含有干细胞胞外囊泡的药物组合物及其在呼吸道炎症治疗中的应用
CN113522384A (zh) * 2021-07-06 2021-10-22 温州医科大学附属眼视光医院 一种微流控芯片及其制备与应用
CN114480260B (zh) * 2022-01-24 2024-02-09 同济大学 一种成体肺干细胞外泌体及其制备方法和应用
CN115181724A (zh) * 2022-06-10 2022-10-14 浙江工业大学 一种间充质干细胞来源的外泌体及其制备方法与应用
WO2024143644A1 (fr) * 2022-12-30 2024-07-04 한국과학기술연구원 Vésicules extracellulaires dérivées de plantes modifiées en surface et système d'administration de médicament ciblée l'utilisant
CN116622608A (zh) * 2023-05-31 2023-08-22 华中科技大学 一种诱导自裂解型抗抑郁工程菌株及其应用
TWI925442B (zh) * 2024-01-08 2026-05-11 大陸商亦及之洲生物科技(蘇州)有限公司 用於治療脫髮和/或白髮的工程化外泌體及其組合物和用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102063069B1 (ko) * 2011-03-11 2020-01-08 칠드런'즈 메디컬 센터 코포레이션 중간엽 줄기 세포 엑소솜에 관련된 방법 및 조성물
US20150018227A1 (en) * 2011-08-05 2015-01-15 University Of Louisville Research Foundation, Inc. Microrna biomarkers
EP3470073A1 (fr) 2012-04-03 2019-04-17 Reneuron Limited Microparicules de cellules souches
WO2014022852A1 (fr) * 2012-08-03 2014-02-06 Aptamir Therapeutics, Inc. Administration cellulaire spécifique de modulateurs de miarn pour le traitement de l'obésité et de troubles associés
JP6137894B2 (ja) * 2013-03-22 2017-05-31 国立大学法人京都大学 リポソーム−エキソソームハイブリッドベシクル及びその調製法
WO2015002956A1 (fr) 2013-07-01 2015-01-08 Ohio State Innovation Foundation Système de distribution d'exosome
EA201890006A1 (ru) * 2015-06-10 2018-05-31 Борд Оф Риджентс, Дзе Юниверсити Оф Техас Систем Применение экзосом для лечения болезни
WO2017075708A1 (fr) 2015-11-05 2017-05-11 Exerkine Corporation Exosomes utiles pour traiter la fibrose kystique (cf)
KR20190100174A (ko) * 2016-12-23 2019-08-28 엑소팜 리미티드 미세소포 및 엑소좀의 정제 또는 단리를 위한 방법 및 조성물
CN107625727B (zh) * 2017-08-10 2020-01-10 中国人民解放军第三O二医院 一种地塞米松纳米脂质体的胶体水溶液及其制备方法和应用
WO2020030817A1 (fr) * 2018-08-10 2020-02-13 Omnispirant Limited Vésicules extracellulaires pour inhalation

Also Published As

Publication number Publication date
JP7480143B2 (ja) 2024-05-09
AU2019316742B2 (en) 2024-11-14
WO2020030817A1 (fr) 2020-02-13
IL280658B1 (en) 2026-01-01
IL280658B2 (en) 2026-05-01
US20240315980A1 (en) 2024-09-26
BR112021002286A2 (pt) 2021-05-04
SG11202100870UA (en) 2021-02-25
KR102875565B1 (ko) 2025-10-23
CL2021000334A1 (es) 2021-06-18
CN112566626A (zh) 2021-03-26
EP3833331A1 (fr) 2021-06-16
US20210308067A1 (en) 2021-10-07
MX2021001574A (es) 2021-07-15
KR20210042351A (ko) 2021-04-19
NZ772069A (en) 2025-08-29
US12029821B2 (en) 2024-07-09
AU2019316742A1 (en) 2021-02-11
JP2021534237A (ja) 2021-12-09
CA3108605A1 (fr) 2020-02-13
IL280658A (en) 2021-03-25
ZA202100886B (en) 2025-05-28

Similar Documents

Publication Publication Date Title
IL280658A (en) Extracellular vesicles for inhalation
IL277344A (en) Extracellular vesicles containing agonist-STING
EP4009989A4 (fr) Vésicules extracellulaires thérapeutiques
IL286556A (en) Extracellular vesicles for vaccine delivery
EP3727351A4 (fr) Vésicules extracellulaires modifiées pour une administration tissulaire améliorée
EP3661556A4 (fr) Vésicules extracellulaires synthétiques pour nouvelles thérapies
EP3852770A4 (fr) Vésicules extracellulaires modifiées en surface
MA50087A (fr) Vésicules extracellulaires provenant de prevotella
MA50086A (fr) Vésicules extracellulaires (ev) bactériennes
EP3630078A4 (fr) Agents pour chimio-embolisation
EP3426261A4 (fr) Ligands de ciblage pour composés thérapeutiques
HUE051792T2 (hu) Humán vérlemezke lizátumból származó extracelluláris vezikulák gyógyászatban való alkalmazásra
EP3423044A4 (fr) Nanovaccin activant sting pour l'immunothérapie
EP3393911A4 (fr) Station d'accueil autonome pour drones
EP3430024A4 (fr) Vésicules membranaires thérapeutiques
EP3525735A4 (fr) Ultrasons thérapeutiques pour troubles oculaires
EP3344295A4 (fr) Récepteurs d'antigène chimère tn anti-sialyle
EP3250706A4 (fr) Vésicules extracellulaires pour l'administration d'un agent
IT201900024580A1 (it) Vescicole extracellulari da microalghe
EP3380177A4 (fr) Bronchoscope pour voies respiratoires
IL280851A (en) Targeted extracellular vesicles
EP3445428A4 (fr) Dispositif d'espacement pour inhalateur
EP3704341A4 (fr) Latte pour volet roulant
EP3307268A4 (fr) Phenyl-oxazolidinones substituées pour la thérapie antimicrobienne
EP3730141A4 (fr) Agent thérapeutique pour la pollakiurie nocturne